The Impact of Hormonal Contraception on Bone Mineral Density in Young Women: A Retrospective Study
Creators
- 1. Senior Resident, Department of Obstetrics and Gynaecology, Indira Gandhi Institute of Medical Science, Patna, Bihar, India
- 2. Junior Resident, Department of Obstetrics and Gynaecology, Indira Gandhi Institute of Medical Science, Patna, Bihar, India
- 3. Junior Resident, Department of Obstetrics and Gynecology, Indira Gandhi Institute of Medical Science, Patna, Bihar, India
- 4. Senior Resident, Department of Obstetrics & Gynecology, Indira Gandhi Institute of Medical Science, Patna, Bihar, India
Description
Background: Hormonal contraception has transformed family planning, but its possible impacts on the bone health of young women remain a source of concern. Given the significance of Bone Mineral Density (BMD) to bone health, it is essential to investigate the potential association between hormonal contraception and BMD. Methods: This retrospective investigation included 200 women between 18 and 30 who attended the Indira Gandhi Institute of Medical Science in Patna, Bihar, India. The study participants who claimed to utilise hormonal contraceptives were compared to those who did not. BMD was quantified using dual-energy X-ray absorptiometry scans. BMD changes were analysed statistically about birth control methods. Results: The results demonstrated that different contraceptive methods caused distinct variations in BMD. The BMD of the average oral contraceptive user decreased by 2.61 per cent, whereas the BMD of the average hormonal intrauterine device user increased by 2.48 per cent. The BMD of injectable contraceptive users decreased by 1.69 per cent, whereas the BMD of non-users (controls) increased by 0.80 per cent. Conclusion: This study illuminates the complex association between hormonal contraception and BMD in young women. These results emphasise the significance of delivering individualised contraception advice to address issues related to bone health. This study clarifies the complex interaction between hormonal contraception and BMD, allowing women to make better decisions for their overall health.
Abstract (English)
Background: Hormonal contraception has transformed family planning, but its possible impacts on the bone health of young women remain a source of concern. Given the significance of Bone Mineral Density (BMD) to bone health, it is essential to investigate the potential association between hormonal contraception and BMD. Methods: This retrospective investigation included 200 women between 18 and 30 who attended the Indira Gandhi Institute of Medical Science in Patna, Bihar, India. The study participants who claimed to utilise hormonal contraceptives were compared to those who did not. BMD was quantified using dual-energy X-ray absorptiometry scans. BMD changes were analysed statistically about birth control methods. Results: The results demonstrated that different contraceptive methods caused distinct variations in BMD. The BMD of the average oral contraceptive user decreased by 2.61 per cent, whereas the BMD of the average hormonal intrauterine device user increased by 2.48 per cent. The BMD of injectable contraceptive users decreased by 1.69 per cent, whereas the BMD of non-users (controls) increased by 0.80 per cent. Conclusion: This study illuminates the complex association between hormonal contraception and BMD in young women. These results emphasise the significance of delivering individualised contraception advice to address issues related to bone health. This study clarifies the complex interaction between hormonal contraception and BMD, allowing women to make better decisions for their overall health.
Files
IJPCR,Vol15,Issue9,Article89.pdf
Files
(440.1 kB)
Name | Size | Download all |
---|---|---|
md5:deacfc98f595f7213cf2e0c94df4b429
|
440.1 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-08-29
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue9,Article89.pdf
- Development Status
- Active
References
- 1. G. S. Merki-Feld and J. Bitzer, Contraception in adolescents with anorexia nervosa. is there evidence for a negative impact of combined hormonal contraceptives on bone mineral density and the course of the disease? The European Journal of Contraception & Reproductive Health Care, 2020; 25(3) 213–220. 2. R. C. Roden, G. Noritz, E. R. McKnight, and A. E. Bonny, An exploratory study of Depotmedroxyprogesterone acetate and bone mineral density in adolescent and young adult women with cerebral palsy, Contraception, 2020; 101(4): 273–275. 3. J. Li, N. Yuan, H. Wang, and W. Qingzhong, Advances in clinical application of bone mineral density and bone turnover markers, Biomechanical and Mechanobiological Analysis of Bone Mineral Density [Working Title], 2022. 4. K. Talash and M. Bukhari, Fri0503 using bone mineral density versus the ratio of body mass index to bone mineral density to predict fracture risk in hyperthyroidism, Poster Presentations, 2019. 5. M. Mohseni, S. Eisen, S. Stum, and R. Civitelli, The association of pelvic bone mineral density and with proximal femoral and spine bone mineral density in post-menopausal women, Journal of Clinical Densitometry, 2022; 25(3):3 28–333, 2022. 6. P. K. Fazeli, Low bone mineral density in anorexia nervosa: Treatments and challenges, Clinical Reviews in Bone and Mineral Metabolism, 2019; 17(2): 65–76. 7. J. H. Won and S. H. Jung, Bone mineral density in adults with cerebral palsy, Frontiers in Neurology, 2021;12. 8. A. da Rizzo et al., One-year adolescent bone mineral density and bone formation marker changes through the use or lack of use of combined hormonal contraceptives, Jornal de Pediatria, 2019; 95(5): 567–574. 9. Orlaghfeehan, P4-02-03 - polyunsaturated fatty acids and their relationship with bone mineral density and markers of bone turnover in postmenopausal women, 2019. 10. M. Bellver, L. Del Rio, E. Jovell, F. Drobnic, and A. Trilla, Bone mineral density and bone mineral content among female elite athletes, Bone, 2019; 127:393–400. 11. K. Talash and M. Bukhari, Fri0503 using bone mineral density versus the ratio of body mass index to bone mineral density to predict fracture risk in hyperthyroidism, Poster Presentations, 2019. 12. J. Guillebaud, Combined hormonal contraception, Contraception Today, 2019; 13–85.13. D. LEE, The impact of obesity on the accuracy of DXA BMD for DXA-equivalent BMD estimation., 2022. 14. S. Yang, Review for mechanisms underlying the association of beta blocker use and bone mineral density, 2020. 15. J. A. Russell and K. M. Oliver, Mechanisms underlying microbial symbiosis, Advances in Insect Physiology, 2020; 1–25.